Please enable Javascript
Sara Tolaney, MD, MPH
Sara Tolaney, MD, MPH, is from the Dana-Farber Cancer Institute.
Articles by Sara Tolaney, MD, MPH
HER2CLIMB-02 Study Data Assesses Trastuzumab Plus Tucatinib in Patients With HER2+ Breast Cancer: How Does This Fit Into the Treatment Paradigm?
Oncology Brothers
HER2 Breast Cancer
|
March 26, 2025
Will HER2CLIMB-02 study data impact the breast cancer landscape?
View More